GHRH and neoplasm: This hypothesis, however, does not exclude a possibility that GHRH agonists may also bind to an unknown homologous G-protein coupled receptor and directly inhibit the IGF-1 production in both hepatic and tumor cells as proposed by Kineman for the actions of GHRH antagonists [37].